27 February 2024 Dimerix: DATA COLLECTION COMPLETE FOR FIRST INTERIM ANALYSIS IN ACTION3 PHASE 3 CLINICAL TRIAL FOR FSGS KIDNEY DISEASE 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post